Research

At present, 44 countries, including the European Union, have banned or are phasing out atrazine due to concern for its negative effects on human health.

The Vanderbilt-Ingram Cancer Center 25th Annual Scientific Retreat will focus on hereditary cancers and feature nationally and internationally renowned speakers on the subject.

A new interactive tool presents information on noncoding RNA in extracellular vesicles — agents of cell-cell communication that may have a future in medical diagnosis and therapeutics.

Vanderbilt's Alexander Bick, MD, PhD, has received a Hevolution/AFAR New Investigator Award in Aging Biology and Geroscience Research from the American Federation for Aging Research (AFAR) and Hevolution Foundation.

An analysis of the genomes of more than 1 million people of European ancestry, conducted by several of the world’s leading genomic centers, including Vanderbilt University Medical Center, has identified more than 2,000 independent genetic signals for blood pressure.

A Vanderbilt study found that Black and white people who earned less than $15,000 a year died, on average, more than 10 years earlier than those whose annual income exceeded $50,000.

An anticancer drug blunted atherosclerosis progression — and even made plaques shrink — in a mouse model of the disease, opening new opportunities for preventing and treating this leading cause of death.